Ontology type: schema:ScholarlyArticle Open Access: True
2014-02
AUTHORSNicola J Jordan, Carol M Dutkowski, Denise Barrow, Huw J Mottram, Iain R Hutcheson, Robert I Nicholson, Sylvie M Guichard, Julia MW Gee
ABSTRACTINTRODUCTION: Upregulation of PI3K/Akt/mTOR signalling in endocrine-resistant breast cancer (BC) has identified mTOR as an attractive target alongside anti-hormones to control resistance. RAD001 (everolimus/Afinitor®), an allosteric mTOR inhibitor, is proving valuable in this setting; however, some patients are inherently refractory or relapse during treatment requiring alternative strategies. Here we evaluate the potential for novel dual mTORC1/2 mTOR kinase inhibitors, exemplified by AZD8055, by comparison with RAD001 in ER + endocrine resistant BC cells. METHODS: In vitro models of tamoxifen (TamR) or oestrogen deprivation resistance (MCF7-X) were treated with RAD001 or AZD8055 alone or combined with anti-hormone fulvestrant. Endpoints included growth, cell proliferation (Ki67), viability and migration, with PI3K/AKT/mTOR signalling impact monitored by Western blotting. Potential ER cross-talk was investigated by immunocytochemistry and RT-PCR. RESULTS: RAD001 was a poor growth inhibitor of MCF7-derived TamR and MCF7-X cells (IC50 ≥1 μM), rapidly inhibiting mTORC1 but not mTORC2/AKT signalling. In contrast AZD8055, which rapidly inhibited both mTORC1 and mTORC2/AKT activity, was a highly effective (P <0.001) growth inhibitor of TamR (IC50 18 nM) and MCF7-X (IC50 24 nM), and of a further T47D-derived tamoxifen resistant model T47D-tamR (IC50 19 nM). AZD8055 significantly (P <0.05) inhibited resistant cell proliferation, increased cell death and reduced migration. Furthermore, dual treatment of TamR or MCF7-X cells with AZD8055 plus fulvestrant provided superior control of resistant growth versus either agent alone (P <0.05). Co-treating with AZD8055 alongside tamoxifen (P <0.01) or oestrogen deprivation (P <0.05) also effectively inhibited endocrine responsive MCF-7 cells. Although AZD8055 inhibited oestrogen receptor (ER) ser167 phosphorylation in TamR and MCF7-X, it had no effect on ER ser118 activity or expression of several ER-regulated genes, suggesting the mTOR kinase inhibitor impact was largely ER-independent. The capacity of AZD8055 for ER-independent activity was further evidenced by growth inhibition (IC5018 and 20 nM) of two acquired fulvestrant resistant models lacking ER. CONCLUSIONS: This is the first report demonstrating dual mTORC1/2 mTOR kinase inhibitors have potential to control acquired endocrine resistant BC, even under conditions where everolimus fails. Such inhibitors may prove of particular benefit when used alongside anti-hormonal treatment as second-line therapy in endocrine resistant disease, and also potentially alongside anti-hormones during the earlier endocrine responsive phase to hinder development of resistance. More... »
PAGESr12
http://scigraph.springernature.com/pub.10.1186/bcr3604
DOIhttp://dx.doi.org/10.1186/bcr3604
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1051068164
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/24457069
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Agents, Hormonal",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Combined Chemotherapy Protocols",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Breast Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cell Line, Tumor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cell Movement",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cell Proliferation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Resistance, Neoplasm",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Synergism",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Estradiol",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Estrogen Antagonists",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Estrogen Receptor Antagonists",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Everolimus",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Immunosuppressive Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "MCF-7 Cells",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mechanistic Target of Rapamycin Complex 1",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mechanistic Target of Rapamycin Complex 2",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Morpholines",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Multiprotein Complexes",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Phosphatidylinositol 3-Kinases",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Proto-Oncogene Proteins c-akt",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptors, Estrogen",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Sirolimus",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "TOR Serine-Threonine Kinases",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Tamoxifen",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Cardiff University",
"id": "https://www.grid.ac/institutes/grid.5600.3",
"name": [
"Breast Cancer (Molecular Pharmacology) Group, Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, King Edward VII Avenue, CF10 3NB, Cardiff, UK",
"CUPUCI, School of Medicine, Cardiff University, Henry Wellcome Building, Heath Park, CF14 4XN, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "Jordan",
"givenName": "Nicola J",
"id": "sg:person.0745061654.61",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745061654.61"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cardiff University",
"id": "https://www.grid.ac/institutes/grid.5600.3",
"name": [
"Breast Cancer (Molecular Pharmacology) Group, Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, King Edward VII Avenue, CF10 3NB, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "Dutkowski",
"givenName": "Carol M",
"id": "sg:person.0601630021.19",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601630021.19"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cardiff University",
"id": "https://www.grid.ac/institutes/grid.5600.3",
"name": [
"Breast Cancer (Molecular Pharmacology) Group, Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, King Edward VII Avenue, CF10 3NB, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "Barrow",
"givenName": "Denise",
"id": "sg:person.01277511160.33",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277511160.33"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cardiff University",
"id": "https://www.grid.ac/institutes/grid.5600.3",
"name": [
"Breast Cancer (Molecular Pharmacology) Group, Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, King Edward VII Avenue, CF10 3NB, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "Mottram",
"givenName": "Huw J",
"id": "sg:person.0651243266.50",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651243266.50"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cardiff University",
"id": "https://www.grid.ac/institutes/grid.5600.3",
"name": [
"Department of Pharmacology, Therapeutics & Toxicology, Cardiff University School of Medicine, UHW Main Building, Heath Park, CF14 4XN, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "Hutcheson",
"givenName": "Iain R",
"id": "sg:person.01143104710.88",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143104710.88"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cardiff University",
"id": "https://www.grid.ac/institutes/grid.5600.3",
"name": [
"Breast Cancer (Molecular Pharmacology) Group, Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, King Edward VII Avenue, CF10 3NB, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "Nicholson",
"givenName": "Robert I",
"id": "sg:person.0670333460.58",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670333460.58"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "AstraZeneca (United Kingdom)",
"id": "https://www.grid.ac/institutes/grid.417815.e",
"name": [
"Oncology, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, Cheshire, UK"
],
"type": "Organization"
},
"familyName": "Guichard",
"givenName": "Sylvie M",
"id": "sg:person.01030073162.90",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030073162.90"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cardiff University",
"id": "https://www.grid.ac/institutes/grid.5600.3",
"name": [
"Breast Cancer (Molecular Pharmacology) Group, Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, King Edward VII Avenue, CF10 3NB, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "Gee",
"givenName": "Julia MW",
"id": "sg:person.012457220672.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012457220672.07"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1186/bcr3493",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000009450",
"https://doi.org/10.1186/bcr3493"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/cad.0b013e328363adc5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000434545"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/cad.0b013e328363adc5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000434545"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/cad.0b013e328363adc5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000434545"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1677/joe-10-0137",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1001744518"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-11-2123",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002320398"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/b:brea.0000014042.54925.cc",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1003505449",
"https://doi.org/10.1023/b:brea.0000014042.54925.cc"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1146/annurev-med-070909-182917",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1003635865"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1371/journal.pbio.1000038",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007831702"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1677/erc-10-0070",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009717768"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/ncb1183",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010840444",
"https://doi.org/10.1038/ncb1183"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/ncb1183",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010840444",
"https://doi.org/10.1038/ncb1183"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/0008-5472.can-08-3014",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011584965"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature03205",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011820890",
"https://doi.org/10.1038/nature03205"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature03205",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011820890",
"https://doi.org/10.1038/nature03205"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10549-005-9070-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011886505",
"https://doi.org/10.1007/s10549-005-9070-2"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10549-005-9070-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011886505",
"https://doi.org/10.1007/s10549-005-9070-2"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1515/hmbci-2011-0004",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1013612457"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.steroids.2011.02.035",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015151570"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/b:brea.0000041623.21338.47",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015249151",
"https://doi.org/10.1023/b:brea.0000041623.21338.47"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.febslet.2009.11.041",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1016028445"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/0008-5472.can-05-2925",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1016365658"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.bmcl.2010.05.099",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1016653936"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1006/abio.2001.5116",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1016745833"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1042/bst0390456",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017510763"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1042/bst0390456",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017510763"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1530/erc-10-0046",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017918868"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bjc.2012.368",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019124743",
"https://doi.org/10.1038/bjc.2012.368"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1172/jci41680",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019843818"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1172/jci41680",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019843818"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1677/erc.1.00778",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019974670"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1677/erc.1.00778",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019974670"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-04-2402",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021045381"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-09-1823",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021164391"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/a:1025484908380",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021361015",
"https://doi.org/10.1023/a:1025484908380"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3816/cbc.2010.s.016",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023228375"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3816/cbc.2010.s.016",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023228375"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/bcr2833",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023415107",
"https://doi.org/10.1186/bcr2833"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-04-0035",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026116949"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1677/erc.1.01006",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026820864"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/bcr3330",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1027649563",
"https://doi.org/10.1186/bcr3330"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1371/journal.pmed.0050008",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028686736"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.bbapap.2009.12.001",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028875134"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/2159-8290.cd-11-0085",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028907775"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1109653",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029978324"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bjc.6603353",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030175427",
"https://doi.org/10.1038/sj.bjc.6603353"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bjc.6603353",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030175427",
"https://doi.org/10.1038/sj.bjc.6603353"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1677/erc.1.00991",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030919324"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.18632/oncotarget.188",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031055488"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-04-0112",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032492266"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ejca.2007.10.003",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032760666"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdm170",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033167972"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1210/en.2002-220620",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033760962"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/b:clin.0000037697.76011.1d",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034162687",
"https://doi.org/10.1023/b:clin.0000037697.76011.1d"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1074/jbc.m807532200",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034864098"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1349-7006.2012.02359.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1036139267"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/0008-5472.can-05-0917",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1036814851"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2004.08.116",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037649097"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1042/bj20112107",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038156496"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1042/bj20112107",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038156496"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2005.66.130",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040834618"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2005.66.130",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040834618"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/0008-5472.can-09-1751",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1043962324"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrd3531",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044264191",
"https://doi.org/10.1038/nrd3531"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ygyno.2012.08.040",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044592924"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2007.14.5482",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044922442"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2011.39.0708",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046132060"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11523-011-0177-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046635626",
"https://doi.org/10.1007/s11523-011-0177-6"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdi113",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047165477"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/bcr1289",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047505573",
"https://doi.org/10.1186/bcr1289"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1242/jcs.051011",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049581720"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.molcel.2006.03.029",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051144156"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3816/cbc.2003.n.018",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051659558"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1349-7006.2008.00955.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052326292"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2011.339",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052501115",
"https://doi.org/10.1038/leu.2011.339"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1126/science.273.5272.239",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1062553595"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1538-7445.am2012-917",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1063246961"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1210/en.2005-0247",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064247375"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.4161/auto.6.4.11671",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1072290689"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.4161/cbt.9.9.11432",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1072295752"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.4161/cc.7.24.7244",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1072299800"
],
"type": "CreativeWork"
}
],
"datePublished": "2014-02",
"datePublishedReg": "2014-02-01",
"description": "INTRODUCTION: Upregulation of PI3K/Akt/mTOR signalling in endocrine-resistant breast cancer (BC) has identified mTOR as an attractive target alongside anti-hormones to control resistance. RAD001 (everolimus/Afinitor\u00ae), an allosteric mTOR inhibitor, is proving valuable in this setting; however, some patients are inherently refractory or relapse during treatment requiring alternative strategies. Here we evaluate the potential for novel dual mTORC1/2 mTOR kinase inhibitors, exemplified by AZD8055, by comparison with RAD001 in ER\u2009+\u2009endocrine resistant BC cells.\nMETHODS: In vitro models of tamoxifen (TamR) or oestrogen deprivation resistance (MCF7-X) were treated with RAD001 or AZD8055 alone or combined with anti-hormone fulvestrant. Endpoints included growth, cell proliferation (Ki67), viability and migration, with PI3K/AKT/mTOR signalling impact monitored by Western blotting. Potential ER cross-talk was investigated by immunocytochemistry and RT-PCR.\nRESULTS: RAD001 was a poor growth inhibitor of MCF7-derived TamR and MCF7-X cells (IC50 \u22651 \u03bcM), rapidly inhibiting mTORC1 but not mTORC2/AKT signalling. In contrast AZD8055, which rapidly inhibited both mTORC1 and mTORC2/AKT activity, was a highly effective (P\u2009<0.001) growth inhibitor of TamR (IC50 18\u2009nM) and MCF7-X (IC50 24 nM), and of a further T47D-derived tamoxifen resistant model T47D-tamR (IC50 19 nM). AZD8055 significantly (P\u2009<0.05) inhibited resistant cell proliferation, increased cell death and reduced migration. Furthermore, dual treatment of TamR or MCF7-X cells with AZD8055 plus fulvestrant provided superior control of resistant growth versus either agent alone (P\u2009<0.05). Co-treating with AZD8055 alongside tamoxifen (P\u2009<0.01) or oestrogen deprivation (P\u2009<0.05) also effectively inhibited endocrine responsive MCF-7 cells. Although AZD8055 inhibited oestrogen receptor (ER) ser167 phosphorylation in TamR and MCF7-X, it had no effect on ER ser118 activity or expression of several ER-regulated genes, suggesting the mTOR kinase inhibitor impact was largely ER-independent. The capacity of AZD8055 for ER-independent activity was further evidenced by growth inhibition (IC5018 and 20 nM) of two acquired fulvestrant resistant models lacking ER.\nCONCLUSIONS: This is the first report demonstrating dual mTORC1/2 mTOR kinase inhibitors have potential to control acquired endocrine resistant BC, even under conditions where everolimus fails. Such inhibitors may prove of particular benefit when used alongside anti-hormonal treatment as second-line therapy in endocrine resistant disease, and also potentially alongside anti-hormones during the earlier endocrine responsive phase to hinder development of resistance.",
"genre": "research_article",
"id": "sg:pub.10.1186/bcr3604",
"inLanguage": [
"en"
],
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.5139406",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1022375",
"issn": [
"1465-5411",
"1465-542X"
],
"name": "Breast Cancer Research",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "16"
}
],
"name": "Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro",
"pagination": "r12",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"f34524ad4b683441bdf9249ed2af1172b0056581bbf27ca4cb58b56e4eb5fac9"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"24457069"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"100927353"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/bcr3604"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1051068164"
]
}
],
"sameAs": [
"https://doi.org/10.1186/bcr3604",
"https://app.dimensions.ai/details/publication/pub.1051068164"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-10T16:43",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000516.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1186%2Fbcr3604"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/bcr3604'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/bcr3604'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/bcr3604'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/bcr3604'
This table displays all metadata directly associated to this object as RDF triples.
452 TRIPLES
21 PREDICATES
124 URIs
47 LITERALS
35 BLANK NODES